Women continue to be underrepresented in clinical trial leadership, corresponding with a lack of gender diversity among presenters at scientific meetings, according to a review published in the Journal of the American College of Cardiology.
An analysis of CV trials published during the last 4 years showed women comprised only 10.1% of clinical trial leadership committees; more than half of the trials had no women as part of the trial leadership team. Historically, clinical trials have largely enrolled white men and participation has been low among women, older adults and racial and ethnic